GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 399 filers reported holding GUARDANT HEALTH INC in Q4 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,022,610 | -15.0% | 911,694 | +2.7% | 0.09% | -6.5% |
Q2 2023 | $31,790,794 | +143.0% | 888,011 | +59.1% | 0.09% | +135.9% |
Q1 2023 | $13,085,052 | -12.1% | 558,236 | +2.0% | 0.04% | -15.2% |
Q4 2022 | $14,892,272 | -47.2% | 547,510 | -4.3% | 0.05% | -54.5% |
Q3 2022 | $28,197,000 | +128.2% | 571,888 | +86.7% | 0.10% | +173.0% |
Q2 2022 | $12,355,000 | -34.5% | 306,260 | +7.5% | 0.04% | -24.5% |
Q1 2022 | $18,874,000 | -35.2% | 284,923 | -2.1% | 0.05% | -27.9% |
Q4 2021 | $29,118,000 | -22.9% | 291,115 | -3.6% | 0.07% | -29.9% |
Q3 2021 | $37,748,000 | -0.8% | 301,964 | -1.5% | 0.10% | 0.0% |
Q2 2021 | $38,059,000 | -20.8% | 306,455 | -2.7% | 0.10% | -29.7% |
Q1 2021 | $48,059,000 | +14.7% | 314,831 | -3.2% | 0.14% | +23.2% |
Q4 2020 | $41,905,000 | +16.1% | 325,141 | +0.7% | 0.11% | +4.7% |
Q3 2020 | $36,100,000 | +33.3% | 322,952 | -3.2% | 0.11% | +17.6% |
Q2 2020 | $27,081,000 | +13.9% | 333,790 | -2.2% | 0.09% | -8.1% |
Q1 2020 | $23,766,000 | – | 341,457 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |